Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome

1999/01/07 by Karl Rickels, K. Rickels, E. Schweizer +9 · 6 citations
Medicine · #Adverse effect #Alprazolam #Anesthesia #Anticonvulsant #Antidepressant #Anxiety #Benzodiazepine #Bipolar Disorder and Treatment #Diazepam #Discontinuation #Epilepsy #Epilepsy research and treatment #Internal medicine #Lorazepam #Medicine #Nausea #Placebo #Psychiatry #Schizophrenia research and treatment #Sedation #Trazodone

paper · doi:10.1007/s002130050798

crossref issued 1999/01/07 · crossref published 1999/01/07 · crossref published-print 1999/01/07 · openalex publication_date 1999/01/07 · crossref created 2002/08/25 · crossref deposited 2019/05/23 · openalex created_date 2025/10/10 · crossref indexed 2026/04/11 · openalex updated_date 2026/08/01

Cited by

• Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
• Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta‐analysis
• Strategies for discontinuing long-term benzodiazepine use
• Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation
• Clinical application of paroxetine for tapering benzodiazepine use in non‐major‐depressive outpatients visiting an internal medicine clinic
• Benzodiazepine withdrawal syndrome [wikipedia]